SecBot SecBot

Maternal and Infant Syphilis Prevention Act

H.R. 8839 Rep. Yadira Caraveo (D-CO-8) In committee
Bill text PDF
  1. Introduced Jun 26
  2. Committee Jun 26
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jun 26, 2024Next: House vote
855d ago Jun 26, 2024: Referred to the House Committee on Energy and Commerce.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Subscribe to see spend
Member trades
1trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Medical Devices & Healthcare 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill requires the Secretary of Health and Human Services to issue guidance to states on best practices for screening and treating congenital syphilis under Medicaid and the Children's Health Insurance Program (CHIP).

Sec. 3, Guidance to states and technical assistance under Medicaid and CHIP: Within 12 months of enactment, the Secretary must issue guidance to state Medicaid agencies on best practices for improving access to syphilis screening for pregnant women and babies, educating medical professionals and pregnant women, integrating telehealth services, increasing testing in the third trimester and at delivery, and improving treatment. The guidance may include using waivers under section 1115 of the Social Security Act and authorities under Medicaid and CHIP. Within 2 years, the Secretary must submit a report to Congress analyzing state implementation of these best practices.

Summary of the bill text as introduced in House (Jun 26, 2024), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.